Autism & I/DD

Intellectual and developmental disabilities (I/DD) are a physical and/or cognitive impairments that occur before the age of 22. Autism spectrum disorder is generally considered a type of developmental disability that affects behaviour and communication. The autism and I/DD market provides supports and health care services to these populations. Over the past decade, there has been an increase in the changes and challenges affecting I/DD and autism markets—the move to managed care and value-based care, the shift away from residential treatment, the increasing emphasis on consumer-directed care, and new workforce challenges.

Latest Resources

• The Autism Market Recalibration
• Sevita Health Must Divest 128 Intermediate Care Facilities To Close BrightSpring Acquisition
• Behavior Frontiers Opens Four New ABA Therapy Centers In Minneapolis
• Catalight & Frontera Partner To Reduce Cost & Improve Quality Of Autism Care
• Community Autism Services Opens New Autism Learning Center In Massachusetts
• Unintended Housing Consequences
• New York OPWDD Launches Home-Enabling Supports Program To Expand Use Of Assistive Technology For I/DD Population
• Autism Researchers Form Independent Committee As Counter To Changes In The Federal Interagency Autism Coordinating Committee
• Nebraska Adopts New Disability Assessment Tool; Some Beneficiaries See Reduced Services
• Breaking the Revolving Door: How an Intensive Crisis Stabilization Center Is Reducing ER Reliance
• AnswersNow Completes $40 Million Series B To Expand BCBA-Driven, AI-Enabled Autism Therapy
• Karuna Care Services Expands To Littleton, Colorado
• Amigo AI Raises $11 Million Series A Funding To Advance How Clinical AI Agents Are Trained
• ‘Strategic Productivity’ In A Hybrid Care Environment: The Southwest Behavioral & Health Services Case Study
• Are You CCBHC-Ready? Preparing for the 2026 SAMHSA Funding Cycle

See All

90% Of Chilean Children With Autism Have Medical Comorbidities

About 90% of children with autism in Chile have at least one medical comorbidity. More than half had insomnia (61%) or were overweight (52%). About 28% had allergic rhinitis or atopic dermatitis, and 27% had constipation. Researchers analyzed a retrospective chart review of 544 children diagnosed with autism between 2015 and 2023 at a specialized pediatric neurodevelopmental center in Chile. The children’s comorbid medical conditions were identified through standardized caregiver interviews, clinical examination, body measurements,… Read

• A Replicable Framework For Tech Adoption In I/DD Services: The NuPath Case Study
• Parc Center For Disabilities Announces Children’s Services Center Opening
• Adults With I/DDs Had Higher Prevalence Of Anxiety & Depression & More Barriers To Care
• ‘What Will Happen When I’m Gone?’: Parents Of People With Disabilities Push To Expand Services
• Journal Retracts Study On Leucovorin As Autism Treatment Cited In Federal Policy Announcement

To sign-up for monthly Autism & I/DD Services alerts, you must be signed in to your account.